Tags
Results for: Mulvaney Lab
-
Article Item
Hard-to-treat cancers respond to combination therapy using a new class of drugs , articleIn a powerful new approach, Fralin Biomedical Research Institute scientists use advanced gene editing to study potential dual therapy for lung, brain, and pancreatic cancers.
Date: Jul 25, 2025 - -
Article Item
Finding community and focus in interdisciplinary cancer research , articleDoctoral student Blanka Bordas had not planned to work in Washington, D.C., as she earned her degree, but opted to do so for the chance to work with an outstanding mentor on cancer research
Date: Apr 11, 2025 - -
Article Item
Scientist awarded National Institutes of Health grant to examine cancer-related enzyme , articleKathleen Mulvaney, assistant professor with the Fralin Biomedical Research Institute’s Cancer Research Center — D.C., will investigate the basic biology of PRMT5, an enzyme that can be found in 15 percent of human cancers.
Date: Sep 10, 2024 - -
Article Item
Rare Disease Day brings worldwide attention to more than 7,000 rare diseases , articleVirginia Tech research into rare diseases — those that individually affect 200,000 or fewer but collectively touch 1 in 10 people in the U.S. — provides hope in identifying, treating, and supporting patients.
Date: Feb 28, 2024 - -
Article Item
From healthy development to cancer treatments, Fralin Biomedical Research Institute scientists aim for impact , articleNew Seale Innovation Fund projects fuel a broad spectrum of research focused on cardiovascular disease, diabetes, cancer, stress, brain development, and more.
Date: Jan 29, 2024 - -
Article Item
2023 marks a year of firsts for Translational Biology, Medicine, and Health Graduate Program , articleThe interdisciplinary program saw its first student assigned full-time to a Fralin Biomedical Research Institute lab in Washington, D.C., its first students from Nepal and Ghana in an internationally diverse incoming cohort, and its first student to be awarded a prestigious grant for future physician-scientists.
Date: Dec 15, 2023 - -
Article Item
New cancer drug shows promise in targeting genetic weakness in tumors, Virginia Tech expert says , articleIn an invited review article in Cancer Discovery, a journal of the American Association for Cancer Research, Kathleen Mulvaney, assistant professor with the Fralin Biomedical Research Institute at VTC, talks about the potential of a new drug that has shown early promise in clinical trials for solid tumors by killing cancer cells that lack specific genes.
Date: Nov 01, 2023 - -
Article Item
Common challenge, different strategies: Virginia Tech Cancer Research Alliance gathers broad mix of researchers and clinicians , articleThe second annual Virginia Tech Cancer Research Alliance retreat, hosted this year on the Children’s National Research & Innovation Campus, brought together scientists and physicians on the leading edge of developing innovative therapy types, fresh biological targets, and new technologies to take on cancer.
Date: Jun 21, 2023 - -
Article Item
New cancer biologist targets ‘Achilles heel’ in deadly brain cancers , articleCancer biologist Kathleen Mulvaney joins the faculty of the Fralin Biomedical Research Institute at VTC on Oct. 1. Her lab will be in Washington, D.C., on the Children’s National Research & Innovation Campus as part of a partnership between Virginia Tech and Children’s National.
Date: Sep 27, 2022 -